Ocular pharmacology involves the study of drugs and their effects on the eyes. Pharmacodynamics in ocular pharmacology focuses on how drugs interact with ocular tissues to produce their therapeutic effects. The pharmacodynamic properties of ocular drugs are crucial in understanding their mechanisms of action, including how they affect receptors and signalling pathways within the eye.
For example, drugs targeting the ciliary muscle can alter the shape of the lens, influencing accommodation and addressing conditions like myopia or hyperopia. Glaucoma medications often target intraocular pressure by modulating aqueous humor production or enhancing its drainage. Anti-inflammatory agents can mitigate ocular inflammation by suppressing immune responses.
The unique anatomy and physiology of the eye require tailored pharmacodynamic approaches. Understanding these interactions is essential for developing effective ocular medications that provide optimal therapeutic outcomes while minimizing side effects. Ocular pharmacodynamics plays a pivotal role in the design and optimization of drugs for various eye conditions, ensuring their efficacy and safety in maintaining ocular health.
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary